Author: Rajiv Nanjapla

Rajiv Nanjapla started working at Market Realist in 2015 and has been covering the restaurant, home improvement, tobacco, and cannabis sectors. He holds a post-graduate diploma in finance and operations.

Since Andrew Yang announced his presidential run, he's advocated for cannabis legalization. He says existing cannabis policies are "deeply racist."

Despite Aurora Cannabis providing higher-than-expected guidance for fiscal 2019's fourth quarter early this year, its stock has fallen 25.6% this month.

Currently, Tilray is trading 27% higher than its 52-week low of $27.65. The stock is trading at a discount of 88.3% from its 52-week high of $300.

Canopy Growth (WEED) (CGC) will report its fiscal 2020 first-quarter earnings results today after the market closes.

Tilray (TLRY) reported its second-quarter earnings after the market closed on Tuesday. The company reported revenues of $45.9 million.

Piper Jaffray has rated Cronos Group as “overweight.” The investment company has given Cronos Group a 12-month price target of $18.

Today, MedMen Enterprises (MMEN) (MMNFF) reported its unaudited revenue for the fourth quarter of fiscal 2019.

As of Monday, CannTrust was trading at 3.04 Canadian dollars. The company has lost 53.6% of its stock value since the beginning of July.

Kevin O’Leary’s interest in cannabis stocks favors medicinal use over recreational use. We look at the changing landscape of the US cannabis industry.

Tilray (TLRY) is set to report its second-quarter earnings after markets close tomorrow. Analysts expect its revenue to rise over 320% year-over-year.